COMPANY INFO
MicroTransponder, Inc. was founded in 2007 by Jordan Curnes and Navzer Engineer, with additional founding contributions from Rosellini, Cauller, and Richard Weiner. The company is headquartered in Austin, Texas, and has approximately 138 employees. MicroTransponder develops the Paired Vagus Nerve Stimulation (Paired VNS™) platform, including the FDA-approved Vivistim® System for post-stroke upper limb impairment, aimed at improving quality of life for patients with chronic neurological conditions. It operates in the medical equipment manufacturing industry, focusing on neurostimulation devices for neurological disease treatment.
MicroTransponder Inc. is a medical device company headquartered in Austin, Texas, specializing in neurostimulation technologies for improving the quality of life of patients with chronic neurological conditions. The company is best known for its Paired Vagus Nerve Stimulation (Paired VNS™) platform, including the FDA-approved Vivistim® System for stroke recovery.
MicroTransponder Inc. has cultivated an accomplished management team, combining deep expertise in neuroscience, commercial strategy, clinical development, and operational excellence. The MicroTransponder Inc. leadership is composed of seasoned executives and founders whose collective experience spans major healthcare companies, medical device innovation, and successful commercialization of transformative therapies. Together, the MicroTransponder Inc. executives drive innovation, global market expansion, and execution of the company’s long-term vision.
Richard Foust is Chief Executive Officer, providing strategic direction and commercial leadership for MicroTransponder Inc. Richard spearheads company-wide growth initiatives, leveraging his expertise in scaling medical device organizations and executing go-to-market strategies. Under his guidance, the company has accelerated adoption of its Vivistim® System and expanded its presence in the healthcare market.
He holds a BS in Applied Physics from Emory University and a Master's in Bioengineering from Georgia Institute of Technology. Richard brings over two decades of experience, previously serving in key leadership roles at Abbott, Analyte Health, Honor, Velano Vascular, and 3D Strategy Consulting, making him a pivotal figure in MicroTransponder Inc.'s management team.
Navzer Engineer, MD, PhD, serves as Co-Founder and Chief Scientific Officer. Navzer is instrumental in developing the Paired VNS™ platform, anchoring the scientific advancements that differentiate MicroTransponder Inc. He has led groundbreaking research in neuroplasticity and vagus nerve stimulation, secured several NIH grants, and published in top scientific journals, significantly advancing the company's clinical foundation.
Navzer completed medical training in India and earned a PhD in Neuroscience from the University of Texas at Dallas. As inventor of numerous neurostimulation patents, his profound subject matter expertise and innovative drive are central to MicroTransponder Inc.'s leadership in neuromodulation.
Jordan Curnes, MBA, is Co-Founder & President of MicroTransponder Inc., and has been pivotal in company formation, commercialization, and team scaling activities. Jordan's leadership in business development and operational strategy has fueled growth and guided strategic partnerships, supporting the company’s evolution from startup to industry leader.
He earned a finance degree from Notre Dame and an MBA from Duke University. Jordan is a serial entrepreneur, with prior experience at Huron Consulting Group, where he advised large healthcare corporations, fortifying his management acumen within MicroTransponder Inc.'s executive team.
Prashant Rawat is Chief Operating Officer, overseeing research and development, clinical programs, regulatory operations, and manufacturing. Prashant's global leadership has been critical in introducing novel therapies across neurostimulation, neurovascular, and cardiac care, while fortifying MicroTransponder Inc.'s intellectual property portfolio.
Educated at Maharaja Sayajirao University (BS, Electronics Engineering) and Case Western Reserve University (MS, Electrical Engineering and Applied Physics), Prashant is inventor on over 85 patents. His deep technical and operational background strengthens the efficiency and innovation capacity of MicroTransponder Inc. management.
Bunker Curnes serves as Chief Financial Officer, managing financial operations and corporate strategy to support MicroTransponder Inc.'s sustainable growth. Since joining in 2011, Bunker has contributed to successful funding rounds and operational scaling, and previously held CFO positions at HEMCO Development and TEGA Technologies as well as a consultancy role with Boston Consulting Group.
Bunker earned a BS in Mechanical Engineering from the University of Notre Dame and an MBA from Duke University's Fuqua School of Business. His comprehensive finance and management expertise ensure sound fiscal stewardship within the MicroTransponder Inc. leadership team.
Doug Ellison is Chief Commercial Officer, directing sales and marketing operations critical to bringing MicroTransponder Inc.'s therapies to market. With 33 years in executive management within medical devices, Doug has advanced the company’s commercial growth and market expansion through strategic leadership.
Doug holds a BS in Engineering from Purdue University and formerly served in senior roles at AtriCure, SentreHEART, Cardica Inc., and Guidant Corp. His background reinforces the business development strengths found throughout the MicroTransponder Inc. management team.
Brent Tarver leads clinical affairs, orchestrating pivotal trials and overseeing clinical strategy for new therapies at MicroTransponder Inc. Brent's 30 years of expertise in vagus nerve stimulation and distinguished record in clinical trial management underpin critical company milestones, including the US IDE trial for stroke therapy.
He holds an electrical engineering degree from Rice University, with substantial experience in both clinical development and neurostimulation devices, making him a vital part of MicroTransponder Inc. leadership.
Spencer Bailey spearheads market access and reimbursement strategies, leveraging nearly 20 years in healthcare consulting and reimbursement leadership. He supports MicroTransponder Inc. in securing coverage and driving adoption of its treatments across healthcare systems.
Spencer earned dual degrees in accounting (BS) and business administration (MBA) from the University of Vermont and is a Certified Professional Coder. His background enables MicroTransponder Inc. to effectively navigate market access and payer environments.
Mary Kathryn Williams heads commercial operations and analytics, optimizing business processes and applying analytic rigor to drive performance at MicroTransponder Inc. With over 15 years’ experience in medical devices, Mary Kathryn has been instrumental in supporting business development and operational efficiency.
She holds a BS in Biology from Washington & Lee University and an MBA from Duke University. Her prior work includes commercial roles at Abbott and Terumo Aortic.
Rob Hadley leads sales in the Eastern United States, focusing on commercialization of MicroTransponder Inc.'s therapies. With over 27 years' experience in biotech and medical device sales, Rob has managed high-performing sales teams and executed effective market-entry strategies for advanced therapies.
Rob previously held senior sales roles at Avail Medsystems, SentreHeart, Abbott Vascular, Guidant Corporation, and Merck Human Health, contributing effective commercial leadership to the MicroTransponder Inc. management team.
The MicroTransponder Inc. leadership team brings together accomplished professionals across entrepreneurship, science, commercial operations, finance, and clinical development—a synergy that supports the company’s innovative edge in therapeutic devices. The company's executive structure balances foundational scientific innovation from its founders with operational and commercial depth, empowering MicroTransponder Inc. to set new standards for stroke recovery and neurostimulation therapies.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the MicroTransponder Inc. leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.